Marathon Capital Management’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.28M | Sell |
102,911
-742
| -0.7% | -$55.6K | 1.63% | 19 |
|
|
2025
Q4 | $8.18M | Sell |
103,653
-882
| -0.8% | -$69.8K | 1.76% | 15 |
|
|
2025
Q3 | $8.61M | Sell |
104,535
-2,252
| -2% | -$177K | 1.97% | 12 |
|
|
2025
Q2 | $8.59M | Sell |
106,787
-2,160
| -2% | -$167K | 2.19% | 9 |
|
|
2025
Q1 | $8.75M | Sell |
108,947
-1,294
| -1% | -$108K | 2.33% | 8 |
|
|
2024
Q4 | $9.03M | Sell |
110,241
-123
| -0.1% | -$10.2K | 2.25% | 9 |
|
|
2024
Q3 | $9.1M | Sell |
110,364
-522
| -0.5% | -$39K | 2.21% | 10 |
|
|
2024
Q2 | $7.78M | Sell |
110,886
-5,710
| -5% | -$408K | 1.98% | 10 |
|
|
2024
Q1 | $8.64M | Sell |
116,596
-528
| -0.5% | -$36.8K | 2.06% | 10 |
|
|
2023
Q4 | $7.75M | Buy |
117,124
+107
| +0.1% | +$6.7K | 1.95% | 8 |
|
|
2023
Q3 | $7.36M | Sell |
117,017
-685
| -0.6% | -$42.7K | 1.85% | 11 |
|
|
2023
Q2 | $6.65M | Sell |
117,702
-2,487
| -2% | -$138K | 1.64% | 11 |
|
|
2023
Q1 | $6.96M | Buy |
120,189
+28,285
| +31% | +$1.91M | 1.71% | 11 |
|
|
2022
Q4 | $6.65M | Sell |
91,904
-13,210
| -13% | -$946K | 1.83% | 10 |
|
|
2022
Q3 | $6.39M | Sell |
105,114
-70
| -0.1% | -$4.47K | 1.83% | 10 |
|
|
2022
Q2 | $6.6M | Buy |
105,184
+225
| +0.2% | +$14.9K | 2.13% | 3 |
|
|
2022
Q1 | $7.38M | Sell |
104,959
-1,499
| -1% | -$101K | 2.12% | 3 |
|
|
2021
Q4 | $6.65M | Buy |
106,458
+35
| +0% | +$2.2K | 1.56% | 6 |
|
|
2021
Q3 | $6.57M | Buy |
106,423
+25
| +0% | +$1.5K | 1.49% | 5 |
|
|
2021
Q2 | $6.37M | Sell |
106,398
-169
| -0.2% | -$10.7K | 1.47% | 6 |
|
|
2021
Q1 | $6.48M | Buy |
106,567
+1,880
| +2% | +$104K | 1.71% | 4 |
|
|
2020
Q4 | $4.92M | Sell |
104,687
-2,342
| -2% | -$101K | 1.45% | 8 |
|
|
2020
Q3 | $3.98M | Sell |
107,029
-7,426
| -6% | -$282K | 1.45% | 6 |
|
|
2020
Q2 | $4.18M | Buy |
114,455
+74,825
| +189% | +$2.6M | 1.61% | 5 |
|
|
2020
Q1 | $1.21M | Sell |
39,630
-1,400
| -3% | -$62.1K | 0.56% | 28 |
|
|
2019
Q4 | $2.09M | Buy |
41,030
+200
| +0.5% | +$9.65K | 0.71% | 24 |
|
|
2019
Q3 | $1.93M | Sell |
40,830
-5,625
| -12% | -$268K | 0.78% | 21 |
|
|
2019
Q2 | $2.31M | Sell |
46,455
-550
| -1% | -$25.9K | 0.94% | 16 |
|
|
2019
Q1 | $2M | Buy |
47,005
+50
| +0.1% | +$2.21K | 0.89% | 19 |
|
|
2018
Q4 | $1.93M | Sell |
46,955
-645
| -1% | -$27.7K | 0.96% | 16 |
|
|
2018
Q3 | $2.22M | Buy |
47,600
+7,235
| +18% | +$331K | 0.86% | 25 |
|
|
2018
Q2 | $1.76M | Buy |
40,365
+6,025
| +18% | +$281K | 0.66% | 31 |
|
|
2018
Q1 | $1.57M | Buy |
+34,340
| New | +$1.67M | 0.62% | 35 |
|
Other funds holding MET
VCM
VPM
Marathon Capital Management's MET Position: Q1 2026 in Review
Marathon Capital Management reduced its MetLife (MET) stake by 0.72% in Q1 2026, selling an estimated $55.6K and leaving 102,911 shares worth $7.28M. The position accounts for 1.63% of the portfolio, ranked #19.
Marathon Capital Management first reported a position in MET in Q1 2018 and has held it in 33 quarters since. The position peaked at $9.1M in Q3 2024. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.
- Marathon Capital Management held 102,911 shares of MetLife worth $7.28M as of Q1 2026.
- Marathon Capital Management sold 742 MetLife shares in Q1 2026, an estimated $55.6K.
- MetLife made up 1.63% of Marathon Capital Management's portfolio in Q1 2026, its #19 holding.
- Marathon Capital Management first reported a position in MetLife in Q1 2018 and has held it in 33 quarters since.
- Marathon Capital Management's MetLife position peaked at $9.1M in Q3 2024.
- 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.
Based on Marathon Capital Management's 13F filing for Q1 2026, filed 14 May 2026.